NCT06077760 · Interventional trial
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
Overall registry status Active not recruiting
Phase 3
Conditions Non-small Cell Lung Cancer
Delaware Valley sites
- Thomas Jefferson University - Clinical Research Institute ( Site 0006) · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory